Discrepancy between Clinical and Final Pathological Evaluation Findings in Early Gastric Cancer Patients Treated with Endoscopic Submucosal Dissection
- PMID: 27104025
- PMCID: PMC4834619
- DOI: 10.5230/jgc.2016.16.1.34
Discrepancy between Clinical and Final Pathological Evaluation Findings in Early Gastric Cancer Patients Treated with Endoscopic Submucosal Dissection
Abstract
Purpose: Early gastric cancer cases that are estimated to meet indications for treatment before endoscopic submucosal resection are often revealed to be out-of-indication after the treatment. We investigated the short-term treatment outcomes in patients with early gastric cancer according to the pretreatment clinical endoscopic submucosal resection indications.
Materials and methods: We retrospectively reviewed the medical records of patients with early gastric cancer that met the pretreatment endoscopic submucosal resection indications, from 2004 to 2011. Curative resection rate and proportion of out-of-indication cases were compared according to the pre-endoscopic submucosal resection indications. Pre-endoscopic submucosal resection factors associated with out-of-indication in the final pathological examination were analyzed.
Results: Of 756 cases, 660 had absolute and 96 had expanded pre-endoscopic submucosal resection indications. The curative resection rate was significantly lower in the patients with expanded indications (64.6%) than in those with absolute indications (81.7%; P<0.001). The cases with expanded indications (30.2%) were revealed to be out-of-indication more frequently than the cases with absolute indications (13.8%; P<0.001). Age of >65 years, tumor size of >2 cm, tumor location in the upper-third segment of the stomach, and undifferentiated histological type in pre-endoscopic submucosal resection evaluations were significant risk factors for out-of-indication after endoscopic submucosal resection.
Conclusions: Non-curative resection due to out-of-indication occurred in approximately one-third of the early gastric cancer cases that clinically met the expanded indications before endoscopic submucosal resection. The possibility of additional surgery should be emphasized for patients with early gastric cancers that clinically meet the expanded indications.
Keywords: Criteria; Early gastric cancer; Endoscopic submucosal dissection.
Conflict of interest statement
Figures
Similar articles
-
Suitability of the expanded indication criteria for the treatment of early gastric cancer by endoscopic submucosal dissection: Japanese multicenter large-scale retrospective analysis of short- and long-term outcomes.Scand J Gastroenterol. 2015 Apr;50(4):413-22. doi: 10.3109/00365521.2014.940377. Epub 2015 Jan 30. Scand J Gastroenterol. 2015. PMID: 25635364
-
Current indications of endoscopic submucosal dissection for early gastric cancer in Japan.Jpn J Clin Oncol. 2019 Sep 1;49(9):797-802. doi: 10.1093/jjco/hyz100. Jpn J Clin Oncol. 2019. PMID: 31322655 Review.
-
Gastric cancer treated by endoscopic submucosal dissection or endoscopic mucosal resection in Japan from 2004 through 2006: JGCA nationwide registry conducted in 2013.Gastric Cancer. 2017 Sep;20(5):834-842. doi: 10.1007/s10120-017-0699-4. Epub 2017 Feb 15. Gastric Cancer. 2017. PMID: 28205058
-
Endoscopic Indication of Endoscopic Submucosal Dissection for Early Gastric Cancer Is Not Compatible with Pathologic Criteria in Clinical Practice.Dig Dis Sci. 2019 Feb;64(2):373-381. doi: 10.1007/s10620-018-5324-9. Epub 2018 Oct 11. Dig Dis Sci. 2019. PMID: 30311155
-
AGA Institute Clinical Practice Update: Endoscopic Submucosal Dissection in the United States.Clin Gastroenterol Hepatol. 2019 Jan;17(1):16-25.e1. doi: 10.1016/j.cgh.2018.07.041. Epub 2018 Aug 2. Clin Gastroenterol Hepatol. 2019. PMID: 30077787 Review.
Cited by
-
Re-evaluation of the role of endoscopic submucosal dissection in the treatment of early gastric cancer based on additional gastrectomy results.Medicine (Baltimore). 2024 Oct 11;103(41):e40111. doi: 10.1097/MD.0000000000040111. Medicine (Baltimore). 2024. PMID: 39465800 Free PMC article.
-
Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach.J Gastric Cancer. 2019 Mar;19(1):1-48. doi: 10.5230/jgc.2019.19.e8. Epub 2019 Mar 19. J Gastric Cancer. 2019. PMID: 30944757 Free PMC article. Review. No abstract available.
-
Prediction of Submucosal Invasion for Gastric Neoplasms in Endoscopic Images Using Deep-Learning.J Clin Med. 2020 Jun 15;9(6):1858. doi: 10.3390/jcm9061858. J Clin Med. 2020. PMID: 32549190 Free PMC article.
References
-
- Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3) Gastric Cancer. 2011;14:113–123. - PubMed
-
- Ahn JY, Jung HY, Choi KD, Choi JY, Kim MY, Lee JH, et al. Endoscopic and oncologic outcomes after endoscopic resection for early gastric cancer: 1370 cases of absolute and extended indications. Gastrointest Endosc. 2011;74:485–493. - PubMed
-
- Isomoto H, Shikuwa S, Yamaguchi N, Fukuda E, Ikeda K, Nishiyama H, et al. Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study. Gut. 2009;58:331–336. - PubMed
-
- Gotoda T, Iwasaki M, Kusano C, Seewald S, Oda I. Endoscopic resection of early gastric cancer treated by guideline and expanded National Cancer Centre criteria. Br J Surg. 2010;97:868–871. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous